arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Concentrix Corp

CNXC
$31.11 ▲ +0.16 (+0.53%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
29 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

Concentrix Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B
Dividend Yield —
Revenue Growth -1.2% ↘
Op. Margin -37.1% ↘
ROIC -16.1% ↘
FCF / Share $3.63 ↗
Trailing P/E —
Price / Book 1.1x
FCF Yield 11.7%
Debt / Equity 2.22
info Valuation on last close. End-of-day price, Nov 5, 2026.

29-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.45B
↓ -1.2% —
Net Income Profit after all expenses
$-988.11M
↓ -1887.6% —
Operating Margin Operating profit as % of sales
-37.1%
↓ -1057.4% 16th
FCF / Share Free cash flow per share
$3.63
↑ +5.4% —
Long-Term Debt Long-term obligations
$3.93B
— -0.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
26
Returns
17
Financial Health ↑
27
Cash Quality
13

Dividend History

Dividend / share · sourced from SEC filings
$0.33 Latest / share
+21.0% YoY
+10.0% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 29 quarters